MLchartDataset catalogue

novobiocin

Term · Oncology and biomedicine · MLC-T-ONC-005942

  1. An antibiotic drug used to treat infection.

  2. An aminocoumarin antibiotic, produced by the actinomycete Streptomyces nivens, with antibacterial property. Novobiocin, as well as other aminocoumarin antibiotics, inhibits bacterial DNA synthesis by targeting at the bacteria DNA gyrase and the related enzyme DNA topoisomerase IV. This antibiotic was used to treat infections by gram-positive bacteria.

Table 1. Record
IdentifierMLC-T-ONC-005942
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-005942",
  "term": "novobiocin",
  "field": "Oncology and biomedicine",
  "definitions": [
    "An antibiotic drug used to treat infection.",
    "An aminocoumarin antibiotic, produced by the actinomycete Streptomyces nivens, with antibacterial property. Novobiocin, as well as other aminocoumarin antibiotics, inhibits bacterial DNA synthesis by targeting at the bacteria DNA gyrase and the related enzyme DNA topoisomerase IV. This antibiotic was used to treat infections by gram-positive bacteria."
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/novobiocin/"
}

Record 11,980 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.